A citation-based method for searching scientific literature

Tomoyuki Mizuno, Min Dong, Zachary L Taylor, Laura B Ramsey, Alexander A Vinks. Br J Clin Pharmacol 2022
Times Cited: 8







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.
A S Darwich, K Ogungbenro, A A Vinks, J R Powell, J-L Reny, N Marsousi, Y Daali, D Fairman, J Cook, L J Lesko,[...]. Clin Pharmacol Ther 2017
104
25

Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and Infants.
Joshua C Euteneuer, Tomoyuki Mizuno, Tsuyoshi Fukuda, Junfang Zhao, Kenneth D R Setchell, Louis J Muglia, Alexander A Vinks. Ther Drug Monit 2020
2
100


Electronic Health Record-Embedded Decision Support Platform for Morphine Precision Dosing in Neonates.
Alexander A Vinks, Nieko C Punt, Frank Menke, Eric Kirkendall, Dawn Butler, Thomas J Duggan, DonnaMaria E Cortezzo, Sam Kiger, Tom Dietrich, Paul Spencer,[...]. Clin Pharmacol Ther 2020
18
25

Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population.
Praveen Shukla, Srijib Goswami, Ron J Keizer, Beth Apsel Winger, Sandhya Kharbanda, Christopher C Dvorak, Janel Long-Boyle. Front Pharmacol 2020
12
25

Tips and traps analyzing pediatric PK data.
Brian J Anderson, Nick H G Holford. Paediatr Anaesth 2011
108
25

Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.
U Meresaar, M I Nilsson, J Holmstrand, E Anggård. Eur J Clin Pharmacol 1981
79
12

Phenobarbital maintenance dose requirements in treating neonatal seizures.
J H Fischer, L A Lockman, D Zaske, R Kriel. Neurology 1981
45
12

Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages.
Gina Song, Xueying Sun, Ronald N Hines, D Gail McCarver, Brian G Lake, Thomas G Osimitz, Moire R Creek, Harvey J Clewell, Miyoung Yoon. Drug Metab Dispos 2017
22
12

Morphine pharmacokinetics and pain assessment in premature newborns.
C S Scott, K W Riggs, E W Ling, C E Fitzgerald, M L Hill, R V Grunau, A Solimano, K D Craig. J Pediatr 1999
85
12

Skin conductance versus the modified COMFORT sedation score as a measure of discomfort in artificially ventilated children.
Ann Christin Gjerstad, Kari Wagner, Thore Henrichsen, Hanne Storm. Pediatrics 2008
57
12

Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia.
Renée A Shellhaas, Chee M Ng, Christina H Dillon, John D E Barks, Varsha Bhatt-Mehta. Pediatr Crit Care Med 2013
39
12

Clonidine versus phenobarbital as adjunctive therapy for neonatal abstinence syndrome.
Carrie Brusseau, Tara Burnette, R Eric Heidel. J Perinatol 2020
4
25

Morphine kinetics after diamorphine infusion in premature neonates.
D A Barrett, A C Elias-Jones, N Rutter, P N Shaw, S S Davis. Br J Clin Pharmacol 1991
35
12

Development of phenobarbital glucosidation in the human neonate.
V O Bhargava, L K Garrettson. Dev Pharmacol Ther 1988
9
12



Bioavailability of oral and intramuscular phenobarbital.
C T Viswanathan, H E Booker, P G Welling. J Clin Pharmacol 1978
35
12


Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study.
C E Witt, K E Rudd, P Bhatraju, F P Rivara, S E Hawes, N S Weiss. J Perinatol 2017
28
12

Bioavailabilities of rectal and oral methadone in healthy subjects.
Ola Dale, Pamela Sheffels, Evan D Kharasch. Br J Clin Pharmacol 2004
45
12

Phenobarbital protein binding in neonates.
A M Taburet, C Chamouard, P Aymard, J Y Chevalier, J Costil. Dev Pharmacol Ther 1982
11
12

Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome.
Hong-Guang Xie, Ying Jun Cao, Estelle B Gauda, Alexander G Agthe, Craig W Hendrix, Howard Lee. J Clin Pharmacol 2011
33
12

Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014.
Tyler N A Winkelman, Nicole Villapiano, Katy B Kozhimannil, Matthew M Davis, Stephen W Patrick. Pediatrics 2018
198
12

Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder.
Ruihua Dong, Hongyun Wang, Dandan Li, Liwei Lang, Frank Gray, Yongzhen Liu, Celine M Laffont, Malcolm Young, Ji Jiang, Zeyuan Liu,[...]. Drugs R D 2019
3
33

Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients.
Brooks T McPhail, Chie Emoto, Tsuyoshi Fukuda, Dawn Butler, Jason R Wiles, Henry Akinbi, Alexander A Vinks. J Clin Pharmacol 2020
4
25

The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates.
D A Barrett, J Simpson, N Rutter, T Kurihara-Bergstrom, P N Shaw, S S Davis. Br J Clin Pharmacol 1993
29
12

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block.
Sarah D McAleer, Richard J Mills, Torsten Polack, Tanweer Hussain, Paul E Rolan, Alan D Gibbs, Frank G P Mullins, Ziad Hussein. Drug Alcohol Depend 2003
39
12

Biliary excretion, metabolism and enterohepatic circulation of buprenorphine.
D Brewster, M J Humphrey, M A McLeavy. Xenobiotica 1981
61
12

Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat.
Monica Rodriguez, Ignacio Ortega, Itziar Soengas, Elena Suarez, John C Lukas, Rosario Calvo. J Pharm Pharmacol 2004
58
12

Phenobarbital population pharmacokinetics across the pediatric age spectrum.
Brady S Moffett, Mindl M Weingarten, Marianne Galati, Jennifer L Placencia, Emily A Rodman, James J Riviello, Simon Y Kayyal. Epilepsia 2018
15
12

Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese.
Shuji Goto, Takayuki Seo, Tsukasa Murata, Naoyuki Nakada, Nao Ueda, Takateru Ishitsu, Kazuko Nakagawa. Ther Drug Monit 2007
36
12

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability.
Manoranjenni Chetty, Rachel H Rose, Khaled Abduljalil, Nikunjkumar Patel, Gaohua Lu, Theresa Cain, Masoud Jamei, Amin Rostami-Hodjegan. Front Pharmacol 2014
32
12

Bile acid metabolism in the fetus and newborn.
R Lester. Ciba Found Symp 1979
5
20

Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach.
Amélie Marsot, Véronique Brevaut-Malaty, Renaud Vialet, Audrey Boulamery, Bernard Bruguerolle, Nicolas Simon. Fundam Clin Pharmacol 2014
18
12

Buprenorphine in Neonatal Abstinence Syndrome.
Walter K Kraft. Clin Pharmacol Ther 2018
15
12

P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.
Sarah M Brown, Scott D Campbell, Amanda Crafford, Karen J Regina, Michael J Holtzman, Evan D Kharasch. J Pharmacol Exp Ther 2012
42
12

Developmental changes in morphine clearance across the entire paediatric age range are best described by a bodyweight-dependent exponent model.
Chenguang Wang, Senthilkumar Sadhavisvam, Elke H J Krekels, Albert Dahan, Dick Tibboel, Meindert Danhof, Alexander A Vinks, Catherijne A J Knibbe. Clin Drug Investig 2013
47
12

Pharmacokinetics of morphine infusion in premature neonates.
R Hartley, M Green, M Quinn, M I Levene. Arch Dis Child 1993
51
12


Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.
Stephanie R Faucette, Hongbing Wang, Geraldine A Hamilton, Summer L Jolley, Darryl Gilbert, Celeste Lindley, Bingfang Yan, Masahiko Negishi, Edward L LeCluyse. Drug Metab Dispos 2004
139
12


Liposolubility and protein binding of oxycodone in vitro.
R Pöyhiä, T Seppälä. Pharmacol Toxicol 1994
57
12

Biliary excretion of barbiturates.
C D Klaassen. Br J Pharmacol 1971
46
12

Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation.
Swantje Völler, Robert B Flint, Leo M Stolk, Pieter L J Degraeuwe, Sinno H P Simons, Paula Pokorna, David M Burger, Ronald de Groot, Dick Tibboel, Catherijne A J Knibbe. Eur J Pharm Sci 2017
21
12

Pharmacokinetic models of morphine and its metabolites in neonates:: Systematic comparisons of models from the literature, and development of a new meta-model.
Katrine Rørbæk Knøsgaard, David John Richard Foster, Mads Kreilgaard, Eva Sverrisdóttir, Richard Neil Upton, Johannes N van den Anker. Eur J Pharm Sci 2016
25
12

Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.
Alexander G Agthe, George R Kim, Kay B Mathias, Craig W Hendrix, Raul Chavez-Valdez, Lauren Jansson, Tamorah R Lewis, Myron Yaster, Estelle B Gauda. Pediatrics 2009
110
12

Pharmacokinetics of phenobarbital in childhood.
G Heimann, E Gladtke. Eur J Clin Pharmacol 1977
48
12

Lipophilicity and brain disposition of clonidine and structurally related imidazolidines.
P B Timmermans, A Brands, P A van Zwieten. Naunyn Schmiedebergs Arch Pharmacol 1977
82
12

Bile flow and composition in preterm, term and infant baboons.
R Bhat, G Chari, J Meller, S Ramarao, D Vidyasagar. Biol Neonate 1997
6
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.